ERBB2 and glioblastoma: Ahmed Ahmed N N HER2-Specific chimeric antigen receptor-modified virus-specific T cells for progressive glioblastoma: a phase 1 dose-escalation trial HER2-Specific chimeric antigen receptor-modified virus-specific T cells for progressive glioblastoma: a phase 1 dose-escalation trial JAMA Oncol JAMA Oncol 2017 2017 3 3 8 8 1094 1094 1101 1101 10.1001/jamaoncol.2017.0184 10.1001/jamaoncol.2017.0184 supplied-pmid 28426845?